Autophagy in dementias

Brain Pathology

Volumn 22, Issue 1, 2012, Pages 99-109

  Kragh, Christine Lund ^a   Ubhi, Kiren ^b   Wyss Corey, Tony ^c   Masliah, Eliezer ^b,d  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aging; alpha synuclein; Alzheimer's disease; clearance; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID PRECURSOR PROTEIN; BAFILOMYCIN A1; BECLIN 1; GLYCOPROTEIN GP 120; NEF PROTEIN; PARKIN; TAR DNA BINDING PROTEIN; TAU CRYSTALLIN;

ALZHEIMER DISEASE; AUTOPHAGOSOME; AUTOPHAGY; CONFERENCE PAPER; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DNA POLYMORPHISM; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HIV ASSOCIATED DEMENTIA; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; SHY DRAGER SYNDROME; SIGNAL TRANSDUCTION;

AUTOPHAGY; BRAIN; DEMENTIA; HUMANS; NERVE TISSUE PROTEINS;

EID: 83455243345     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00545.x     Document Type: Conference Paper

References (191)

1. Aarsland D, Ballard CG, Halliday G, (2004) Are Parkinson's disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 17: 137-145. (Pubitemid 39128223)
2. Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J Neuroimmune Pharmacol 4: 190-199.
3. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, Fox HS, (2008) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS ONE 3: e2906.
4. Alirezaei M, Kiosses WB, Fox HS, (2008) Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 4: 963-966.
5. Badadani M, Nalbandian A, Watts GD, Vesa J, Kitazawa M, Su H, et al, (2010) VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS ONE 5:e13183.
6. Bahr BA, Bendiske J, (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83: 481-489. (Pubitemid 35231802)
7. Belly A, Bodon G, Blot B, Bouron A, Sadoul R, Goldberg Y, (2010) CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. J Cell Sci 123 (Pt 17): 2943-2954.
8. Bendiske J, Bahr BA, (2003) Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis-an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol 62: 451-463. (Pubitemid 36560187)
9. Berg TO, Fengsrud M, Stromhaug PE, Berg T, Seglen PO, (1998) Isolation and characterization of rat liver amphisomes. Evidence for fusion of autophagosomes with both early and late endosomes. J Biol Chem 273: 21883-21892. (Pubitemid 28405366)
10. Boland B, Kumar A, Lee S, Platt FM, Wegiel J, Yu WH, Nixon RA, (2008) Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J Neurosci 28: 6926-6937.
11. Boxer AL, Miller BL, (2005) Clinical features of frontotemporal dementia. Alzheimer Dis Assoc Disord 19 (Suppl. 1): S3-S6. (Pubitemid 44378500)
12. Braak H, Braak E, (2000) Pathoanatomy of Parkinson's disease. J Neurol 247 (Suppl. 2): II3-II10.
13. Brown J, Ashworth A, Gydesen S, Sorensen A, Rossor M, Hardy J, Collinge J, (1995) Familial non-specific dementia maps to chromosome 3. Hum Mol Genet 4: 1625-1628.
14. Burn DJ, (2006) Cortical Lewy body disease and Parkinson's disease dementia. Curr Opin Neurol 19: 572-579. (Pubitemid 44760441)
15. Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, et al, (2005) Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Res 8: 227-237. (Pubitemid 41814344)
16. Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ, et al, (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171: 227-240. (Pubitemid 47342406)
17. Carroll-Anzinger D, Al-Harthi L, (2006) Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. J Virol 80: 541-544.
18. Casarejos MJ, Solano RM, Gomez A, Perucho J, de Yebenes JG, Mena MA, (2011) The accumulation of neurotoxic proteins, induced by proteasome inhibition, is reverted by trehalose, an enhancer of autophagy, in human neuroblastoma cells. Neurochem Int 58: 512-520.
19. Centers for Disease Control (2005) HIV/AIDS surveillance report. 1-63, Centers for Disease Control: Atlanta.
20. Centers for Disease Control (2007) HIV/AIDS surveillance report. 1-54, Centers for Disease Control: Atlanta.
21. Chang KA, Suh YH, (2005) Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease. J Pharmacol Sci 97: 461-471.
22. Chu CT, (2006) Autophagic stress in neuronal injury and disease. J Neuropathol Exp Neurol 65: 423-432. (Pubitemid 44297264)
23. Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH, (2009) Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 35: 385-398.
24. Clifford DB, Fagan AM, Holtzman DM, Morris JC, Teshome M, Shah AR, Kauwe JS, (2009) CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology 73: 1982-1987.
25. Conway KA, Lee SJ, Rochet JC, Ding TT, Williamson RE, Lansbury PT Jr, (2000) Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc Natl Acad Sci USA 97: 571-576. (Pubitemid 30070350)
26. Crews L, Patrick C, Achim CL, Everall IP, Masliah E, (2009) Molecular pathology of neuro-AIDS (CNS-HIV). Int J Mol Sci 10: 1045-1063.
27. Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, et al, (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS ONE 5: e9313.
28. Cuervo AM, (2004) Autophagy: in sickness and in health. Trends Cell Biol 14: 70-77. (Pubitemid 38186640)
29. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D, (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305: 1292-1295. (Pubitemid 39129234)
30. Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, Kolodziej P, et al, (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2: 5.
31. Custer SK, Neumann M, Lu H, Wright AC, Taylor JP, (2010) Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and bone. Hum Mol Genet 19: 1741-1755.
32. Dauer W, Przedborski S, (2003) Parkinson's disease: mechanisms and models. Neuron 39: 889-909. (Pubitemid 37130207)
33. Dauer W, Kholodilov N, Vila M, Trillat AC, Goodchild R, Larsen KE, et al, (2002) Resistance of alpha-synuclein null mice to the parkinsonian neurotoxin MPTP. Proc Natl Acad Sci USA 99: 14524-14529. (Pubitemid 35257704)
34. Dawson TM, Dawson VL, (2003) Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822. (Pubitemid 37339614)
35. Dewhurst S, Maggirwar SB, Schifitto G, Gendelman HE, Gelbard HA, (2007) Glycogen synthase kinase 3 beta (GSK-3 beta) as a therapeutic target in neuroAIDS. J Neuroimmune Pharmacol 2: 93-96.
36. Dunn WA Jr, (1990) Studies on the mechanisms of autophagy: formation of the autophagic vacuole. J Cell Biol 110: 1923-1933.
37. Dunn WA Jr, (1990) Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J Cell Biol 110: 1935-1945.
38. Edinger AL, Thompson CB, (2004) Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16: 663-669. (Pubitemid 39463117)
39. Gelman BB, Nguyen TP, (2010) Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes. J Neuroimmune Pharmacol 5: 92-102.
40. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R, (1997) The neuropathogenesis of the AIDS dementia complex. AIDS 11 (Suppl. A): S35-S45.
41. Geser F, Lee VM, Trojanowski JQ, (2010) Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology 30: 103-112.
42. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, et al, (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 290: 985-989.
43. Gisslen M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, et al, (2009) Amyloid and tau cerebrospinal fluid biomarkers in HIV infection. BMC Neurol 9: 63.
44. Goedert M, Spillantini MG, (2011) Pathogenesis of the Tauopathies. J Mol Neurosci 45: 425-431.
45. Gonzalez-Scarano F, Martin-Garcia J, (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5: 69-81. (Pubitemid 40070332)
46. Gozuacik D, Kimchi A, (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906. (Pubitemid 38638851)
47. Gray F, Chretien F, Vallat-Decouvelaere AV, Scaravilli F, (2003) The changing pattern of HIV neuropathology in the HAART era. J Neuropathol Exp Neurol 62: 429-440. (Pubitemid 36560185)
48. Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL, (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19: 407-411. (Pubitemid 40446187)
49. Grossman M, Wood EM, Moore P, Neumann M, Kwong L, Forman MS, et al, (2007) TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol 64: 1449-1454. (Pubitemid 47572668)
50. Gydesen S, Hagen S, Klinken L, Abelskov J, Sorensen SA, (1987) Neuropsychiatric studies in a family with presenile dementia different from Alzheimer and Pick disease. Acta Psychiatr Scand 76: 276-284.
51. Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, Wilkinson GR, et al, (2000) Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. AIDS Res Hum Retroviruses 16: 1491-1502.
52. Haass C, Capell A, Citron M, Teplow DB, Selkoe DJ, (1995) The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type beta-amyloid precursor protein. J Biol Chem 270: 6186-6192.
53. Haberland C, (2010) Frontotemporal dementia or frontotemporal lobar degeneration-overview of a group of proteinopathies. Ideggyogy Sz 63: 87-93.
54. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, et al, (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441: 885-889.
55. Hardy J, Gwinn-Hardy K, (1998) Genetic classification of primary neurodegenerative disease. Science 282: 1075-1079. (Pubitemid 28516229)
56. Hashimoto M, Masliah E, (1999) Alpha-synuclein in Lewy body disease and Alzheimer's disease. Brain Pathol 9: 707-720. (Pubitemid 29470963)
57. Hashimoto M, Rockenstein E, Masliah E, (2003) Transgenic models of alpha-synuclein pathology: past, present, and future. Ann N Y Acad Sci 991: 171-188. (Pubitemid 36793813)
58. Hashimoto M, Kawahara K, Bar-On P, Rockenstein E, Crews L, Masliah E, (2004) The role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease. J Mol Neurosci 24: 343-352. (Pubitemid 41389374)
59. Haughey NJ, Mattson MP, (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J Acquir Immune Defic Syndr 31 (Suppl. 2): S55-S61. (Pubitemid 35190559)
60. Haughey NJ, Nath A, Mattson MP, Slevin JT, Geiger JD, (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 78: 457-467. (Pubitemid 32729974)
61. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, et al, (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75: 2087-2096.
62. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al, (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17: 3-16.
63. Hung SY, Huang WP, Liou HC, Fu WM, (2009) Autophagy protects neuron from Abeta-induced cytotoxicity. Autophagy 5: 502-510.
64. Hurtig H, Trojanowski J, Galvin J, Ewbank D, Schmidt M, Clark C, et al, (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54: 1916-1921. (Pubitemid 30327112)
65. Itakura E, Kishi C, Inoue K, Mizushima N, (2008) Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 19: 5360-5372.
66. Jaeger PA, Wyss-Coray T, (2010) Beclin 1 complex in autophagy and Alzheimer disease. Arch Neurol 67: 1181-1184.
67. Jaeger PA, Pickford F, Sun C-H, Lucin K, Masliah E, Wyss-Coray T, (2009) Regulation of amyloid precursor protein processing by the beclin 1 complex (submitted).
68. Jaeger PA, Pickford F, Sun CH, Lucin KM, Masliah E, Wyss-Coray T, (2010) Regulation of amyloid precursor protein processing by the Beclin 1 complex. PLoS ONE 5: e11102.
69. Jahreiss L, Menzies FM, Rubinsztein DC, (2008) The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic 9: 574-587. (Pubitemid 351351616)
70. Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahl K, Aarsland D, (2006) Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease. Mov Disord 21: 337-342.
71. Jellinger KA, Attems J, (2006)) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol (Berl) 112: 253-260. (Pubitemid 44275880)
72. Kametaka S, Okano T, Ohsumi M, Ohsumi Y, (1998) Apg14p and Apg6/Vps30p form a protein complex essential for autophagy in the yeast, Saccharomyces cerevisiae. J Biol Chem 273: 22284-22291. (Pubitemid 28399786)
73. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y, (2007) HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27: 123-134. (Pubitemid 46006590)
74. Kaul M, Garden GA, Lipton SA, (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994. (Pubitemid 32335850)
75. Kehn-Hall K, Guendel I, Carpio L, Skaltsounis L, Meijer L, Al-Harthi L, et al, (2011) Inhibition of Tat-mediated HIV-1 replication and neurotoxicity by novel GSK3-beta inhibitors. Virology 415: 56-68.
76. Kertesz A, (2010) Frontotemporal dementia, Pick's disease. Ideggyogy Sz 63: 4-12.
77. Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, et al, (2009) Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol 15: 131-138.
78. Kihara A, Kabeya Y, Ohsumi Y, Yoshimori T, (2001) Beclin- phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep 2: 330-335. (Pubitemid 32401529)
79. Kimura S, Noda T, Yoshimori T, (2008) Dynein-dependent movement of autophagosomes mediates efficient encounters with lysosomes. Cell Struct Funct 33: 109-122.
80. Klein WL, Krafft GA, Finch CE, (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci 24: 219-224. (Pubitemid 32204378)
81. Klionsky DJ, Emr SD, (2000) Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721. (Pubitemid 32004796)
82. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, et al, (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441: 880-884.
83. Komatsu M, Wang QJ, Holstein GR, Friedrich VL Jr, Iwata J, Kominami E, et al, (2007) Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration. Proc Natl Acad Sci USA 104: 14489-14494. (Pubitemid 350010651)
84. Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, et al, (2009) Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 186: 255-268.
85. Larsen KE, Sulzer D, (2002) Autophagy in neurons: a review. Histol Histopathol 17: 897-908. (Pubitemid 34784673)
86. Larussa D, Lorenzini P, Cingolani A, Bossolasco S, Grisetti S, Bongiovanni M, et al, (2006) Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retroviruses 22: 386-392. (Pubitemid 43787762)
87. Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S, Callaway DJ, (2002) New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease. J Biol Chem 277: 42881-42890. (Pubitemid 35285665)
88. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury PT Jr, (2002) Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322: 1089-1102. (Pubitemid 35266514)
89. Lee JA, Gao FB, (2008) Roles of ESCRT in autophagy-associated neurodegeneration. Autophagy 4: 230-232.
90. Lee JA, Gao FB, (2009) Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia. J Neurosci 29: 8506-8511.
91. Lee JA, Beigneux A, Ahmad ST, Young SG, Gao FB, (2007) ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr Biol 17: 1561-1567. (Pubitemid 47380392)
92. Lee M, Hyun D, Halliwell B, Jenner P, (2001) Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J Neurochem 76: 998-1009. (Pubitemid 32167373)
93. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, et al, (2007) Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176. (Pubitemid 46095716)
94. Levine B, (2005) Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 120: 159-162. (Pubitemid 40174758)
95. Liang C, Sir D, Lee S, Ou JH, Jung JU, (2008) Beyond autophagy: the role of UVRAG in membrane trafficking. Autophagy 4: 817-820.
96. Liang XH, Kleeman LK, Jiang HH, Gordon G, Goldman JE, Berry G, et al, (1998) Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein. J Virol 72: 8586-8596. (Pubitemid 28471796)
97. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B, (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676. (Pubitemid 129516338)
98. Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, et al, (2007) DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68: 812-819. (Pubitemid 46568532)
99. Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K, Verny M, et al, (1998) Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic study. Arch Neurol 55: 969-978. (Pubitemid 28335116)
100. Maggirwar SB, Tong N, Ramirez S, Gelbard HA, Dewhurst S, (1999) HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73: 578-586. (Pubitemid 29339830)
101. Majeski AE, Dice JF, (2004) Mechanisms of chaperone-mediated autophagy. Int J Biochem Cell Biol 36: 2435-2444. (Pubitemid 39119757)
102. Mandal PK, Pettegrew JW, Masliah E, Hamilton RL, Mandal R, (2006) Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease. Neurochem Res 31: 1153-1162. (Pubitemid 44379676)
103. Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA, (2002) Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J Neurochem 83: 955-963. (Pubitemid 35316046)
104. Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, et al, (2008) Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest 118: 777-788.
105. Marui W, Iseki E, Nakai T, Miura S, Kato M, Ueda K, Kosaka K, (2002) Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 195: 153-159. (Pubitemid 34202293)
106. Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A, (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry 69: 376-380. (Pubitemid 30636242)
107. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L, (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA 98: 12245-12250. (Pubitemid 32959858)
108. Maslow K, (2010) 2010 Alzheimer's disease facts and figures. Alzheimers Dement 6: 158-194.
109. Masui K, Nakata Y, Fujii N, Iwaki T, (2011) Extensive distribution of glial cytoplasmic inclusions in an autopsied case of multiple system atrophy with a prolonged 18-year clinical course. Neuropathology doi: 10.1111/j.1440-1789.2011.01222.x [epub ahead of print].
110. Mattson MP, (2002) Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease. J Neurovirol 8: 539-550. (Pubitemid 36104719)
111. McArthur J, Hoover D, Bacellar H, Miller E, Cohen B, Becker J, et al, (1993) Dementia in AIDS patients: incidence and risk factors. Neurology 43: 2245-2252. (Pubitemid 23346956)
112. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, Nath A, Sacktor N, (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9: 205-221. (Pubitemid 36656454)
113. McArthur JC, Steiner J, Sacktor N, Nath A, (2010) Human immunodeficiency virus-associated neurocognitive disorders: mind the gap. Ann Neurol 67: 699-714.
114. McKeith IG, (2000) Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. Neurol Clin 18: 865-902.
115. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al, (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47: 1113-1124. (Pubitemid 26374873)
116. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al, (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65: 1863-1872. (Pubitemid 43970103)
117. Meredith GE, Totterdell S, Petroske E, Santa Cruz K, Callison RC Jr, Lau YS, (2002) Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease. Brain Res 956: 156-165. (Pubitemid 35335568)
118. Mizushima N, (2004) Methods for monitoring autophagy. Int J Biochem Cell Biol 36: 2491-2502. (Pubitemid 39119761)
119. Nakajima T, Takauchi S, Ohara K, Kokai M, Nishii R, Maeda S, et al, (2005) Alpha-synuclein-positive structures induced in leupeptin-infused rats. Brain Res 1040: 73-80. (Pubitemid 40467494)
120. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, Anafi D, et al, (1999) Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biochem 274: 9843-9846.
121. Nath A, (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186 (Suppl. 2): S193-S198. (Pubitemid 35370481)
122. Nebuloni M, Pellegrinelli A, Ferri A, Bonetto S, Boldorini R, Vago L, et al, (2001) Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients. AIDS 15: 571-575. (Pubitemid 32281351)
123. New DR, Maggirwar SB, Epstein LG, Dewhurst S, Gelbard HA, (1998) HIV-1 Tat induces neuronal death via tumor necrosis factor-alpha and activation of non-N-methyl-D-aspartate receptors by a NFkappaB-independent mechanism. J Biol Chem 273: 17852-17858. (Pubitemid 28355131)
124. Nguyen TP, Soukup VM, Gelman BB, (2010) Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol 176: 893-902.
125. Nixon RA, (2007) Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120 (Pt 23): 4081-4091.
126. Nixon RA, Cataldo AM, (2006) Lysosomal system pathways: genes to neurodegeneration in Alzheimer's disease. J Alzheimers Dis 9 (3 Suppl.): 277-289. (Pubitemid 44253321)
127. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM, (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64: 113-122. (Pubitemid 40349309)
128. Pan T, Kondo S, Zhu W, Xie W, Jankovic J, Le W, (2008) Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement. Neurobiol Dis 32: 16-25.
129. Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, et al, (2011) Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Am J Pathol 178: 1646-1661.
130. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, et al, (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118: 2190-2199. (Pubitemid 351872337)
131. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al, (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820. (Pubitemid 38063704)
132. Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, Amini S, Khalili K, (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65: 458-465. (Pubitemid 29160173)
133. Ravikumar B, Duden R, Rubinsztein DC, (2002) Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum Mol Genet 11: 1107-1117. (Pubitemid 34521091)
134. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, et al, (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36: 585-595. (Pubitemid 38715985)
135. Ravikumar B, Acevedo-Arozena A, Imarisio S, Berger Z, Vacher C, O'Kane CJ, et al, (2005) Dynein mutations impair autophagic clearance of aggregate-prone proteins. Nat Genet 37: 771-776. (Pubitemid 41754897)
136. Rempel HC, Pulliam L, (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19: 127-135. (Pubitemid 40409531)
137. Rideout HJ, Lang-Rollin I, Stefanis L, (2004) Involvement of macroautophagy in the dissolution of neuronal inclusions. Int J Biochem Cell Biol 36: 2551-2562. (Pubitemid 39119766)
138. Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J, et al, (2010) TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 30: 7729-7739.
139. Rockenstein E, Schwach G, Ingolic E, Adame A, Crews L, Mante M, et al, (2005) Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein. J Neurosci Res 80: 247-259. (Pubitemid 40676308)
140. Rubinsztein DC, Ravikumar B, Acevedo-Arozena A, Imarisio S, O'Kane CJ, Brown SD, (2005) Dyneins, autophagy, aggregation and neurodegeneration. Autophagy 1: 177-178.
141. Rusten TE, Simonsen A, (2008) ESCRT functions in autophagy and associated disease. Cell Cycle 7: 1166-1172. (Pubitemid 351749268)
142. Sacktor N, (2002) The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol 8 (Suppl. 2): 115-121. (Pubitemid 36097787)
143. Saito Y, Suzuki K, Hulette C, Murayama S, (2004) Aberrant phosphorylation of alpha-synuclein in human Niemann-Pick type C1 disease. J Neuropathol Exp Neurol 63: 323-328. (Pubitemid 38429029)
144. Sarkar S, Rubinsztein DC, (2008) Small molecule enhancers of autophagy for neurodegenerative diseases. Mol Biosyst 4: 895-901.
145. Schrader-Fischer G, Paganetti PA, (1996) Effect of alkalizing agents on the processing of the beta-amyloid precursor protein. Brain Res 716: 91-100. (Pubitemid 26155223)
146. Scott JC, Woods SP, Carey CL, Weber E, Bondi MW, Grant I, (2011) Neurocognitive consequences of HIV infection in older adults: an evaluation of the "cortical" hypothesis. AIDS Behav 15: 1187-1196.
147. Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC, (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82: 476-486.
148. Sevlever D, Jiang P, Yen SH, (2008) Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species. Biochemistry 47: 9678-9687.
149. Shibata M, Lu T, Furuya T, Degterev A, Mizushima N, Yoshimori T, et al, (2006) Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1. J Biol Chem 281: 14474-14485. (Pubitemid 43848378)
150. Shintani T, Klionsky DJ, (2004) Autophagy in health and disease: a double-edged sword. Science 306: 990-995. (Pubitemid 39482894)
151. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, et al, (2005) Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37: 806-808. (Pubitemid 41077105)
152. Smith G, (2005) Statement of Senator Gordon H Smith. Aging hearing: HIV over fifty, exploring the new threat. In: Senate Committee on Aging: Washington, DC.
153. Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, et al, (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases. J Neurosci 29: 13578-13588.
154. Spilman P, Podlutskaya N, Hart MJ, Debnath J, Gorostiza O, Bredesen D, et al, (2010) Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5: e9979.
155. Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA, (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21: 9549-9560. (Pubitemid 34184043)
156. Steinacker P, Hendrich C, Sperfeld AD, Jesse S, von Arnim CA, Lehnert S, et al, (2008) TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 65: 1481-1487.
157. Sui Z, Sniderhan LF, Fan S, Kazmierczak K, Reisinger E, Kovacs AD, et al, (2006) Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Eur J Neurosci 23: 2623-2634. (Pubitemid 43801454)
158. Tain LS, Mortiboys H, Tao RN, Ziviani E, Bandmann O, Whitworth AJ, (2009) Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat Neurosci 12: 1129-1135.
159. Takeda A, Hashimoto M, Mallory M, Sundsmo M, Hansen L, Sisk A, Masliah E, (1998) Abnormal distribution of the non-Ab component of Alzheimer's disease amyloid precursor/a-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment. Lab Invest 78: 1169-1177. (Pubitemid 28440832)
160. Tayebi N, Callahan M, Madike V, Stubblefield BK, Orvisky E, Krasnewich D, et al, (2001) Gaucher disease and parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 73: 313-321. (Pubitemid 32846370)
161. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L, (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367: 188-193. (Pubitemid 24031702)
162. Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, et al, (2010) VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6: 217-227.
163. Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, et al, (2008) Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases. PLoS ONE 3: e3135.
164. Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, et al, (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60: 307-314. (Pubitemid 36152028)
165. Valcour V, (2009) Aging with HIV. Lessons from CROI 2009. Posit Aware 20: 37-39.
166. Valcour V, Paul R, (2006) HIV infection and dementia in older adults. Clin Infect Dis 42: 1449-1454.
167. Valcour V, Shiramizu B, (2004) HIV-associated dementia, mitochondrial dysfunction, and oxidative stress. Mitochondrion 4: 119-129. (Pubitemid 39549801)
168. Valcour V, Paul R, Neuhaus J, Shikuma C, (2011) The effects of age and HIV on neuropsychological performance. J Int Neuropsychol Soc 17: 190-195.
169. Valcour V, Sithinamsuwan P, Letendre S, Ances B, (2011) Pathogenesis of HIV in the central nervous system. Curr HIV/AIDS Rep 8: 54-61.
170. van der Zee J, Urwin H, Engelborghs S, Bruyland M, Vandenberghe R, Dermaut B, et al, (2008) CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum Mol Genet 17: 313-322.
171. Varkonyi J, Rosenbaum H, Baumann N, MacKenzie JJ, Simon Z, Aharon-Peretz J, et al, (2003) Gaucher disease associated with parkinsonism: four further case reports. Am J Med Genet A 116: 348-351. (Pubitemid 37063588)
172. Volles MJ, Lansbury PT Jr, (2003) Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42: 7871-7878. (Pubitemid 36807703)
173. Wakabayashi K, Takahashi H, (2006) Cellular pathology in multiple system atrophy. Neuropathology 26: 338-345. (Pubitemid 44086838)
174. Walsh DM, Selkoe DJ, (2004) Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 11: 213-228. (Pubitemid 38689025)
175. Walsh DM, Selkoe DJ, (2007) A beta oligomers-a decade of discovery. J Neurochem 101: 1172-1184.
176. Wang JY, Grabacka M, Marcinkiewicz C, Staniszewska I, Peruzzi F, Khalili K, et al, (2006) Involvement of alpha1beta1 integrin in insulin-like growth factor-1-mediated protection of PC12 neuronal processes from tumor necrosis factor-alpha-induced injury. J Neurosci Res 83: 7-18. (Pubitemid 43062005)
177. Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC, (2003) Alpha-Synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278: 25009-25013. (Pubitemid 37548663)
178. Weihl CC, Pestronk A, Kimonis VE, (2009) Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia. Neuromuscul Disord 19: 308-315.
179. Wiley CA, Baldwin M, Achim CL, (1996) Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10: 843-847. (Pubitemid 26229512)
180. Xilouri M, Vogiatzi T, Vekrellis K, Park D, Stefanis L, (2009) Abberant alpha-synuclein confers toxicity to neurons in part through inhibition of chaperone-mediated autophagy. PLoS ONE 4: e5515.
181. Yang B, Akhter S, Chaudhuri A, Kanmogne GD, (2009) HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood-brain barrier: modulatory effects of STAT1 signaling. Microvasc Res 77: 212-219.
182. Yoshida M, (2007) Multiple system atrophy: alpha-synuclein and neuronal degeneration. Neuropathology 27: 484-493. (Pubitemid 47459721)
183. Yu WH, Kumar A, Peterhoff C, Shapiro Kulnane L, Uchiyama Y, Lamb BT, et al, (2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease. Int J Biochem Cell Biol 36: 2531-2540. (Pubitemid 39119764)
184. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, et al, (2005) Macroautophagy-a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171: 87-98. (Pubitemid 41434604)
185. Yue Z, Horton A, Bravin M, DeJager PL, Selimi F, Heintz N, (2002) A novel protein complex linking the delta 2 glutamate receptor and autophagy: implications for neurodegeneration in lurcher mice. Neuron 35: 921-933.
186. Yue Z, Jin S, Yang C, Levine AJ, Heintz N, (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100: 15077-15082. (Pubitemid 37518019)
187. Zeng X, Overmeyer JH, Maltese WA, (2006) Functional specificity of the mammalian Beclin-Vps34 PI 3-kinase complex in macroautophagy versus endocytosis and lysosomal enzyme trafficking. J Cell Sci 119 (Pt 2): 259-270. (Pubitemid 43210695)
188. Zhang S, Salemi J, Hou H, Zhu Y, Mori T, Giunta B, et al, (2010) Rapamycin promotes beta-amyloid production via ADAM-10 inhibition. Biochem Biophys Res Commun 398: 337-341.
189. Zhong Y, Wang QJ, Yue Z, (2009) Atg14L and Rubicon: yin and yang of Beclin 1-mediated autophagy control. Autophagy 5: 890-891.
190. Zhou D, Masliah E, Spector SA, (2011) Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. J Infect Dis 203: 1647-1657.
191. Zhu JH, Horbinski C, Guo F, Watkins S, Uchiyama Y, Chu CT, (2007) Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am J Pathol 170: 75-86. (Pubitemid 47339191)